Peter Galettis

9PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersMicroelectronicsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2025
A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEso.

Jordana Sheahan, Iris Wang, Peter Galettis

|Jan 23, 2024
Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical Practice.

Mirjana Radovanovic, Peter Galettis, Alex Flynn

|Aug 25, 2023
Fluoropolymer Functionalization of Organ-on-Chip Platform Increases Detection Sensitivity for Cannabinoids.

Ziqiu Tong, Lars Esser, Peter Galettis

|Aug 21, 2023
Daily Cannabidiol Administration for 10 Weeks Modulates Hippocampal and Amygdalar Resting-State Functional Connectivity in Cannabis Users: A Functional Magnetic Resonance Imaging Open-Label Clinical Trial.

Valentina Lorenzetti, Eugene McTavish, Samantha Broyd

|Jan 02, 2021
Overcoming barriers to implementing precision dosing with 5-fluorouracil and capecitabine.

Jennifer J Schneider, Peter Galettis, Jennifer H Martin

|Jan 21, 2019
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.

Nadia Solowij, Samantha Broyd, Lisa-Marie Greenwood

Pageof 2

Frequent Collaborators

5 joint publications

Jennifer Martin

4 joint publications

Jennifer Schneider

2 joint publications

Nadia Solowij

2 joint publications

Catherine J Lucas